Bright Minds Biosciences (DRUG) EPS (2019 - 2026)
Bright Minds Biosciences (DRUG) EPS from Dec 31, 2019 to Mar 31, 2026. The TTM Bright Minds Biosciences (DRUG) EPS is -$2.46. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Bright Minds Biosciences (DRUG) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +373.33% |
| 3 Years TTM | -0.14% |
| 5 Years TTM | +8.44% |
| All Time TTM | +25.76% |
Annual EPS change of Bright Minds Biosciences (DRUG)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.80 | -37.63% |
| 2025 | -$1.28 | +165.93% |
| 2024 | -$0.48 | -67.08% |
| 2023 | -$1.46 | -66.68% |
| 2022 | -$4.38 | +16.97% |
| 2021 | -$3.74 | +1203.37% |
| 2020 | -$0.29 | +102.97% |
| 2019 | -$0.14 | N/A |
Comparison Bright Minds Biosciences (DRUG) five years EPS CAGR with competitors
Bright Minds Biosciences (DRUG) five years EPS CAGR is 8.42%.